BUZZ-Tevogen因计划收购数字医疗公司Sciometrix多数股权而上涨

路透中文
Feb 26
BUZZ-Tevogen因计划收购数字医疗公司Sciometrix多数股权而上涨

2月26日 - ** 药物开发商Tevogen Bio TVGN.O股价盘前上涨13.7%至33美分

** 公司签署了收购Sciometrix多数股权的意向书;如果交易成功,Tevogen将获得Clinicus数字医疗平台和远程监控工具的使用权

** 称Sciometrix的技术可帮助Tevogen创收,支持基于价值的医疗服务,并加快药物开发速度

** 财务条款未披露;交易取决于尽职调查、进一步谈判和监管部门的批准 - Tevogen

** 2025 年 TVGN 股价下跌约 68%

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10